BHC Bausch Health Companies Inc.
NYSE · SEC CIK 885590 · EDGAR
- Bought, last 12 months
- $15.62M 1 purchases by 1 insiders
- Sold, last 12 months
- $506.7K 4 sales by 3 insiders
- Filings on record
- 250 since 2021-07-02, latest 2026-08-20 16:33
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| PAULSON & CO. INC. | 10% | $15.62M | — |
| Lenar Aimee J. | Pres, US Pharma | — | $258.9K |
| Lee Frank D. | Dir | — | $132.8K |
| Carson Seana | EVP, GC | — | $115.0K |
| LEE STEVEN HYOSIG | SVP, CAO, Ctrl | — | — |
| GOETTLER MICHAEL | Dir | — | — |
| ROBERTS EIRY | Dir | — | — |
| Charhon Jean-Jacques | EVP, CFO | — | — |
| APPIO THOMAS | CEO, Dir | — | — |
| KAVANAGH SARAH B | Dir | — | — |
Transactions 283
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-28 | 2022-06-24 | BHC | ROBERTSON RUSSEL C | Dir | A - Grant | $0.00 | +34.4K | 162.6K | +27% | $0 | |
| 2022-06-28 | 2022-06-24 | BHC | DE SCHUTTER RICHARD U | Dir | A - Grant | $0.00 | +34.4K | 355.5K | +11% | $0 | |
| 2022-06-28 | 2022-06-24 | BHC | Paulson John | Dir | A - Grant | $0.00 | +34.4K | 121.0K | +40% | $0 | |
| 2022-06-28 | 2022-06-24 | BHC | POWER ROBERT N | Dir | A - Grant | $0.00 | +34.4K | 135.8K | +34% | $0 | |
| 2022-06-28 | 2022-06-24 | BHC | KAVANAGH SARAH B | Dir | A - Grant | $0.00 | +34.4K | 117.4K | +41% | $0 | |
| 2022-06-28 | 2022-06-24 | BHC | WECHSLER AMY B | Dir | A - Grant | $0.00 | +34.4K | 133.7K | +35% | $0 | |
| 2022-06-28 | 2022-06-24 | BHC | Ross Thomas W. Sr. | Dir | A - Grant | $0.00 | +34.4K | 132.3K | +35% | $0 | |
| 2022-06-22 | 2022-06-20 | BHC | Barresi John S | SVP, CAO, Ctrl | A - Grant | $0.00 | +16.9K | 16.9K | New | $0 | |
| 2022-05-17 | 2022-05-13 | BHC | Mulligan Richard | Dir | A - Grant | $0.00 | +2,317 | 2,317 | New | $0 | |
| DM | 2022-05-12 | 2022-05-10 | BHC | APPIO THOMAS | CEO, Dir | M - OptEx | — | +32.0K | 487.7K | +7% | — |
| DM | 2022-05-12 | 2022-05-10 | BHC | Spurr Robert | Pres, U.S. Businesses | M - OptEx | — | +22.2K | 99.1K | +29% | — |
| D | 2022-05-12 | 2022-05-10 | BHC | PAPA JOSEPH C | Dir | F - Tax | $9.40 | -33.7K | 1.43M | -2% | -$316.9K |
| DM | 2022-05-12 | 2022-05-10 | BHC | PAPA JOSEPH C | Dir | M - OptEx | — | +366.1K | 1.21M | +43% | — |
| DM | 2022-05-12 | 2022-05-10 | BHC | Carson Seana | EVP, GC | M - OptEx | — | +7,467 | 71.3K | +12% | — |
| 2022-05-05 | 2022-05-03 | BHC | Munsch Frederick | SVP, CAO, Ctrl | F - Tax | $18.66 | -747 | 22.4K | -3% | -$13.9K | |
| 2022-04-15 | 2022-04-14 | BHC | Spurr Robert | U.S. Pres-Pharma Business | S - Sale | $22.19 | -1,595 | 90.5K | -2% | -$35.4K | |
| 2022-04-04 | 2022-03-31 | BHC | Paulson John | Dir | A - Grant | $22.85 | +1,340 | 86.6K | +2% | +$30.6K | |
| 2022-04-04 | 2022-03-31 | BHC | Miller Steven D | Dir | A - Grant | $22.85 | +1,340 | 63.2K | +2% | +$30.6K | |
| 2022-04-04 | 2022-03-31 | BHC | ICAHN BRETT | Dir | A - Grant | $22.85 | +1,340 | 13.1K | +11% | +$30.6K | |
| 2022-04-04 | 2022-03-31 | BHC | DE SCHUTTER RICHARD U | Dir | A - Grant | $22.85 | +1,504 | 321.1K | +0.5% | +$34.4K | |
| 2022-04-04 | 2022-03-31 | BHC | WECHSLER AMY B | Dir | A - Grant | $22.85 | +300 | 99.4K | +0.3% | +$6,855 | |
| 2022-04-04 | 2022-03-31 | BHC | ROBERTSON RUSSEL C | Dir | A - Grant | $22.85 | +1,668 | 128.3K | +1% | +$38.1K | |
| 2022-03-16 | 2022-03-15 | BHC | Spurr Robert | U.S. Pres-Pharma Business | S - Sale | $22.20 | -4,846 | 92.1K | -5% | -$107.6K | |
| 2022-03-11 | 2022-03-10 | BHC | ACKERMANN CHRISTINA | EVP AND GC | F - Tax | $22.56 | -839 | 162.2K | -0.5% | -$18.9K | |
| 2022-03-10 | 2022-03-08 | BHC | Gordon Joseph F | Pres, Co-Head Bausch, Lomb, Int'l | S - Sale | $21.76 | -3,889 | 93.1K | -4% | -$84.6K | |
| 2022-03-07 | 2022-03-03 | BHC | Spurr Robert | U.S. Pres-Pharma Business | F - Tax | $23.61 | -4,074 | 96.9K | -4% | -$96.2K | |
| 2022-03-07 | 2022-03-03 | BHC | Gordon Joseph F | Pres, Co-Head Bausch, Lomb, Int'l | F - Tax | $23.61 | -4,074 | 97.0K | -4% | -$96.2K | |
| 2022-03-07 | 2022-03-03 | BHC | PAPA JOSEPH C | COB, CEO, Dir | F - Tax | $23.61 | -12.6K | 1.10M | -1% | -$298.5K | |
| 2022-03-07 | 2022-03-03 | BHC | Eldessouky Sam | EVP, CFO | F - Tax | $23.61 | -1,242 | 119.5K | -1% | -$29.3K | |
| 2022-03-07 | 2022-03-03 | BHC | Munsch Frederick | SVP, CAO, Ctrl | F - Tax | $23.61 | -608 | 23.2K | -3% | -$14.4K | |
| 2022-03-07 | 2022-03-03 | BHC | ACKERMANN CHRISTINA | EVP AND GC | F - Tax | $23.61 | -6,926 | 163.1K | -4% | -$163.5K | |
| 2022-03-07 | 2022-03-03 | BHC | APPIO THOMAS | CEO, Pharma Business | F - Tax | $23.61 | -5,564 | 475.3K | -1% | -$131.4K | |
| D | 2022-03-04 | 2022-03-02 | BHC | Spurr Robert | U.S. Pres-Pharma Business | A - Grant | $24.17 | +35.6K | 101.0K | +54% | +$861.1K |
| D | 2022-03-04 | 2022-03-02 | BHC | Spurr Robert | U.S. Pres-Pharma Business | S - Sale | $23.37 | -1,595 | 65.4K | -2% | -$37.3K |
| D | 2022-03-04 | 2022-03-02 | BHC | APPIO THOMAS | CEO, Pharma Business | A - Grant | $0.00 | +152.7K | 480.8K | +47% | $0 |
| 2022-03-04 | 2022-03-02 | BHC | Gordon Joseph F | Pres, Co-Head Bausch, Lomb, Int'l | S - Sale | $23.37 | -11.1K | 101.1K | -10% | -$258.9K | |
| D | 2022-03-02 | 2022-02-27 | BHC | APPIO THOMAS | CEO, Pharma Business | M - OptEx | — | +24.3K | 341.5K | +8% | — |
| DM | 2022-03-02 | 2022-02-26+ | BHC | APPIO THOMAS | CEO, Pharma Business | F - Tax | $24.35 | -13.4K | 328.1K | -4% | -$325.7K |
| DM | 2022-03-02 | 2022-02-27 | BHC | ACKERMANN CHRISTINA | EVP AND GC | F - Tax | $24.35 | -16.0K | 170.0K | -9% | -$390.3K |
| D | 2022-03-02 | 2022-02-27 | BHC | ACKERMANN CHRISTINA | EVP AND GC | M - OptEx | — | +24.3K | 186.0K | +15% | — |
| DM | 2022-03-02 | 2022-02-26+ | BHC | Gordon Joseph F | Pres, Co-Head Bausch, Lomb, Int'l | F - Tax | $24.35 | -9,471 | 120.2K | -7% | -$230.6K |
| D | 2022-03-02 | 2022-02-27 | BHC | Gordon Joseph F | Pres, Co-Head Bausch, Lomb, Int'l | M - OptEx | — | +17.4K | 128.0K | +16% | — |
| D | 2022-03-02 | 2022-03-01 | BHC | Gordon Joseph F | Pres, Co-Head Bausch, Lomb, Int'l | S - Sale+OE | $23.82 | -6,338 | 112.2K | -5% | -$151.0K |
| D | 2022-03-02 | 2022-02-27 | BHC | PAPA JOSEPH C | COB, CEO, Dir | M - OptEx | — | +208.2K | 1.24M | +20% | — |
| DM | 2022-03-02 | 2022-02-26+ | BHC | PAPA JOSEPH C | COB, CEO, Dir | F - Tax | $24.34 | -131.9K | 1.11M | -11% | -$3.21M |
| DM | 2022-03-02 | 2022-02-26+ | BHC | Munsch Frederick | SVP, CAO, Ctrl | F - Tax | $24.35 | -1,958 | 24.4K | -7% | -$47.7K |
| D | 2022-03-02 | 2022-02-27 | BHC | Munsch Frederick | SVP, CAO, Ctrl | M - OptEx | — | +3,330 | 25.7K | +15% | — |
| DM | 2022-03-02 | 2022-02-26+ | BHC | Eldessouky Sam | EVP, CFO | F - Tax | $24.35 | -4,834 | 121.6K | -4% | -$117.7K |
| D | 2022-03-02 | 2022-02-27 | BHC | Eldessouky Sam | EVP, CFO | M - OptEx | — | +8,674 | 125.5K | +7% | — |
| DM | 2022-03-02 | 2022-02-26+ | BHC | Spurr Robert | U.S. Pres-Pharma Business, Dir | F - Tax | $24.35 | -8,925 | 68.6K | -12% | -$217.3K |
| D | 2022-03-02 | 2022-02-27 | BHC | Spurr Robert | U.S. Pres-Pharma Business, Dir | M - OptEx | — | +15.6K | 75.9K | +26% | — |
| 2022-02-17 | 2022-02-15 | BHC | Spurr Robert | U.S. Pres-Pharma Business | S - Sale | $25.02 | -3,251 | 60.3K | -5% | -$81.3K | |
| 2022-01-20 | 2022-01-18 | BHC | Spurr Robert | U.S. Pres-Pharma Business | S - Sale | $26.63 | -3,251 | 63.5K | -5% | -$86.6K | |
| 2022-01-03 | 2021-12-31 | BHC | WECHSLER AMY B | Dir | A - Grant | $27.61 | +249 | 99.1K | +0.3% | +$6,875 | |
| 2022-01-03 | 2021-12-31 | BHC | ROBERTSON RUSSEL C | Dir | A - Grant | $27.61 | +1,380 | 126.6K | +1% | +$38.1K | |
| 2022-01-03 | 2021-12-31 | BHC | Paulson John | Dir | A - Grant | $27.61 | +1,109 | 85.3K | +1% | +$30.6K | |
| 2022-01-03 | 2021-12-31 | BHC | DE SCHUTTER RICHARD U | Dir | A - Grant | $27.61 | +1,245 | 319.6K | +0.4% | +$34.4K | |
| 2022-01-03 | 2021-12-31 | BHC | ICAHN BRETT | Dir | A - Grant | $27.61 | +1,109 | 11.8K | +10% | +$30.6K | |
| 2022-01-03 | 2021-12-31 | BHC | Miller Steven D | Dir | A - Grant | $27.61 | +1,109 | 61.9K | +2% | +$30.6K | |
| 2021-12-30 | 2021-12-15 | BHC | APPIO THOMAS | CEO, Pharma Business | F - Tax | $24.49 | -3,461 | 317.2K | -1% | -$84.8K | |
| 2021-12-02 | 2021-11-30 | BHC | Miller Steven D | Dir | P - Purchase | $24.24 | +50.0K | 60.8K | +464% | +$1.21M | |
| I | 2021-12-02 | 2021-11-30 | BHC | Miller Steven D | Dir | P - Purchase | $24.17 | +10.0K | 10.0K | New | +$241.7K |
| 2021-11-05 | 2021-11-03 | BHC | Munsch Frederick | SVP, CAO, Ctrl | A - Grant | — | +1,246 | 22.4K | +6% | — | |
| 2021-10-05 | 2021-10-01 | BHC | Spurr Robert | U.S. Pres-Pharma Business | F - Tax | $28.60 | -283 | 66.8K | -0.4% | -$8,094 | |
| 2021-10-04 | 2021-09-30 | BHC | DE SCHUTTER RICHARD U | Dir | A - Grant | $27.85 | +1,234 | 318.3K | +0.4% | +$34.4K | |
| 2021-10-04 | 2021-09-30 | BHC | ROBERTSON RUSSEL C | Dir | A - Grant | $27.85 | +1,368 | 125.2K | +1% | +$38.1K | |
| 2021-10-04 | 2021-09-30 | BHC | Miller Steven D | Dir | A - Grant | $27.85 | +1,099 | 10.8K | +11% | +$30.6K | |
| 2021-10-04 | 2021-09-30 | BHC | Paulson John | Dir | A - Grant | $27.85 | +1,099 | 84.2K | +1% | +$30.6K | |
| 2021-10-04 | 2021-09-30 | BHC | WECHSLER AMY B | Dir | A - Grant | $27.85 | +246 | 98.8K | +0.2% | +$6,851 | |
| 2021-10-04 | 2021-09-30 | BHC | ICAHN BRETT | Dir | A - Grant | $27.85 | +1,099 | 10.7K | +11% | +$30.6K | |
| M | 2021-09-15 | 2021-09-13+ | BHC | PAPA JOSEPH C | COB, CEO, Dir | F - Tax | $28.88 | -8,559 | 1.04M | -0.8% | -$247.2K |
| D | 2021-09-03 | 2021-09-01 | BHC | Spurr Robert | Pres, Salix | A - Grant | $0.00 | +9,026 | 67.1K | +16% | $0 |
| D | 2021-09-03 | 2021-09-01 | BHC | APPIO THOMAS | Pres, Co-Head Bausch, Lomb, Int'l | A - Grant | $0.00 | +90.3K | 320.7K | +39% | $0 |
| 2021-08-31 | 2021-08-27 | BHC | ACKERMANN CHRISTINA | EVP AND GC | F - Tax | $28.95 | -5,017 | 161.7K | -3% | -$145.2K | |
| 2021-08-31 | 2021-08-27 | BHC | Spurr Robert | Pres, Salix | F - Tax | $28.95 | -1,278 | 58.1K | -2% | -$37.0K | |
| 2021-08-09 | 2021-08-05 | BHC | VON ESCHENBACH ANDREW C. | Dir | P - Purchase | $25.94 | +1,400 | 38.6K | +4% | +$36.3K | |
| 2021-08-06 | 2021-08-04 | BHC | DE SCHUTTER RICHARD U | Dir | P - Purchase | $25.01 | +10.0K | 317.1K | +3% | +$250.1K | |
| 2021-07-02 | 2021-06-30 | BHC | WECHSLER AMY B | Dir | A - Grant | $29.32 | +234 | 98.6K | +0.2% | +$6,861 | |
| 2021-07-02 | 2021-06-30 | BHC | ROBERTSON RUSSEL C | Dir | A - Grant | $29.32 | +1,300 | 123.8K | +1% | +$38.1K | |
| 2021-07-02 | 2021-06-30 | BHC | DE SCHUTTER RICHARD U | Dir | A - Grant | $29.32 | +1,172 | 307.1K | +0.4% | +$34.4K | |
| 2021-07-02 | 2021-06-30 | BHC | ICAHN BRETT | Dir | A - Grant | $29.32 | +1,044 | 9,559 | +12% | +$30.6K | |
| 2021-07-02 | 2021-06-30 | BHC | Paulson John | Dir | A - Grant | $29.32 | +1,044 | 83.1K | +1% | +$30.6K | |
| 2021-07-02 | 2021-06-30 | BHC | Miller Steven D | Dir | A - Grant | $29.32 | +1,044 | 9,681 | +12% | +$30.6K |
Purchase Sale Sale after option exercise All abbreviations